|
NeoPharm Announces Expansion of Research Relationship With FDA; CRADA Extended Through December 31, 2003.
Publication: Business Wire Publication Date: 28-FEB-01 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2001 Business Wire
Business Editors
LAKE FOREST, Ill.--(BUSINESS WIRE)--Feb. 28, 2001
NeoPharm, Inc. (Nasdaq National Market: NEOL) announced today that it has reached agreement with the FDA to expand the existing Cooperative Research and Development Agreement (CRADA) with the FDA to develop the anti-cancer agent IL13-PE38 for the treatment of tumors that express IL-13 receptors. The term of the CRADA...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Business Wire |
Northwest Mechanics Caution Strike May Still Begin March 12.
February 28, 2001
|
Recruitsoft Strategic Alliance With RecruitUSA Broadens Job Posting Ca...
February 28, 2001
|
Workers' Compensation Medical Costs Lowest in Massachusetts, Says New ...
February 28, 2001
|
Cincinnati Machine Lands Major Profiler Order in China; 3-Spindle, 5-A...
February 28, 2001
|
Sias-MPA -Pernod Ricard Group- Transfers Its 54% Stake in Italcanditi ...
February 28, 2001
|
|
| Find companies classified under Diagnostic substances |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
